Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		A Randomized, Open-Label Phase 3 Study of Temozolomide Added to Whole Brain Radiation Therapy Versus Whole Brain Radiation Therapy Alone for the Treatment of Brain Metastasis From Non-Small Cell Lung Cancer

		Keywords:		Temodar, radiation

		Phase:		Phase 3

		Treatment ID#s:		VT882 NCT00076856

		Age Group:		Adults Only

		Min Karnofsky Score:		70: Cares for self, unable to perform normal activity or to do active work

		Conditions:		Newly Diagnosed: Y Recurrent: Y Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed

		Last Updated:		04/27/2007

		Tumor Types:		Metastatic Brain Tumor


		Comments:

		Treatment Type:		Radiation.

		Contact:		UCLA Medical Center Timothy Cloughesy, MD Director, Neuro-Oncology Program 710 Westwood Plaza Reed Bldg, Room 1-230 Los Angeles, CA 90095 Phone:310-825-5321 Fax: (310)825-0644 Click here to send an email Website: www.neurooncology.ucla.edu

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By